Form 8-K - Current report:
SEC Accession No. 0001193125-23-270370
Filing Date
2023-11-03
Accepted
2023-11-03 16:07:04
Documents
15
Period of Report
2023-10-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d578678d8k.htm   iXBRL 8-K 38777
2 EX-10.1 d578678dex101.htm EX-10.1 41024
3 EX-10.2 d578678dex102.htm EX-10.2 65560
4 EX-10.3 d578678dex103.htm EX-10.3 62718
  Complete submission text file 0001193125-23-270370.txt   380306

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20231030.xsd EX-101.SCH 2842
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20231030_lab.xml EX-101.LAB 17236
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20231030_pre.xml EX-101.PRE 10807
9 EXTRACTED XBRL INSTANCE DOCUMENT d578678d8k_htm.xml XML 3272
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 231376360
SIC: 2834 Pharmaceutical Preparations